Literature DB >> 1417739

Partial purification and characterization of the sodium-ion-coupled 5-hydroxytryptamine transporter of rat cerebral cortex.

D Graham1, H Esnaud, S Z Langer.   

Abstract

A procedure for the extensive purification of the Na(+)-coupled 5-hydroxytryptamine transporter of rat cerebral cortex has been developed. The 5-hydroxytryptamine transporter was solubilized with the non-ionic detergent digitonin, and the detergent extracts were subjected to sequential affinity chromatography on a citalopram-based agarose support and wheat-germ-agglutinin-Sepharose. 5-Hydroxytryptamine transporters in the affinity-purified preparation were identified by using the selective 5-hydroxytryptamine-uptake inhibitor [3H]paroxetine, and were shown to display a similar pharmacological profile to those present in particulate preparations. An overall transporter purification of around 2000-fold was achieved with a 9% recovery. SDS/PAGE of affinity-chromatographed material starting from detergent extracts incubated in the presence or absence of 1 mM-citalopram indicated that a polypeptide of M(r) 73,000 corresponded to the 5-hydroxytryptamine-transporter protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417739      PMCID: PMC1132974          DOI: 10.1042/bj2860801

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  17 in total

1.  Cloning of a serotonin transporter affected by antidepressants.

Authors:  B J Hoffman; E Mezey; M J Brownstein
Journal:  Science       Date:  1991-10-25       Impact factor: 47.728

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter.

Authors:  T Pacholczyk; R D Blakely; S G Amara
Journal:  Nature       Date:  1991-03-28       Impact factor: 49.962

4.  A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.

Authors:  D Graham; H Esnaud; E Habert; S Z Langer
Journal:  Biochem Pharmacol       Date:  1989-11-01       Impact factor: 5.858

5.  Partial purification of the 5-hydroxytryptamine-reuptake system from human blood platelets using a citalopram-derived affinity resin [corrected].

Authors:  E A Biessen; A S Horn; G T Robillard
Journal:  Biochemistry       Date:  1990-04-03       Impact factor: 3.162

6.  Imipramine binding site. Temperature dependence of the binding of 3H-labeled imipramine and 3H-labeled paroxetine to human platelet membrane.

Authors:  P Plenge; E T Mellerup
Journal:  Biochim Biophys Acta       Date:  1984-02-29

7.  Characterization of [3H]paroxetine binding to rat cortical membranes.

Authors:  E Habert; D Graham; L Tahraoui; Y Claustre; S Z Langer
Journal:  Eur J Pharmacol       Date:  1985-11-26       Impact factor: 4.432

8.  Cloning and expression of a rat brain GABA transporter.

Authors:  J Guastella; N Nelson; H Nelson; L Czyzyk; S Keynan; M C Miedel; N Davidson; H A Lester; B I Kanner
Journal:  Science       Date:  1990-09-14       Impact factor: 47.728

9.  Solubilization and characterization of the 5-hydroxytryptamine transporter complex from rat cerebral cortical membranes.

Authors:  E Habert; D Graham; S Z Langer
Journal:  Eur J Pharmacol       Date:  1986-03-18       Impact factor: 4.432

10.  Temperature dependence of drug interaction with the platelet 5-hydroxytryptamine transporter: a clue to the imipramine selectivity paradox.

Authors:  A Segonzac; H Schoemaker; S Z Langer
Journal:  J Neurochem       Date:  1987-02       Impact factor: 5.372

View more
  4 in total

Review 1.  Sodium ion-dependent transporters for neurotransmitters: a review of recent developments.

Authors:  D M Worrall; D C Williams
Journal:  Biochem J       Date:  1994-02-01       Impact factor: 3.857

Review 2.  Paroxetine. A review of its pharmacology, therapeutic use in depression and therapeutic potential in diabetic neuropathy.

Authors:  S M Holliday; G L Plosker
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

3.  Solubilization and characterization of [3H]imipramine and [3H]paroxetine binding sites from calf striatum.

Authors:  A Rotondo; G Giannaccini; C Quattrone; D Marazziti; C Martini; G B Cassano; A Lucacchini
Journal:  Neurochem Res       Date:  1994-10       Impact factor: 3.996

4.  [3H]paroxetine and [3H]citalopram as markers of the human brain 5-HT uptake site: a comparison study.

Authors:  B Arranz; J Marcusson
Journal:  J Neural Transm Gen Sect       Date:  1994
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.